Dyne Therapeutics Ratios (2019-2026) | DYN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Efficiency
Assets Average (Quarter)								479.43M	467.01M	446.27M	406.71M	363.89M	319.85M	303.00M	297.48M	270.03M	228.33M	185.16M	343.68M	674.08M	797.36M	730.04M	706.15M	725.03M	798.03M	1,027.01M	1,133.45M
Equity Average (Quarter)								465.43M	433.36M	391.16M	352.33M	311.76M	268.40M	251.05M	247.15M	224.41M	179.46M	121.67M	284.67M	626.62M	740.37M	667.69M	649.41M	620.21M	631.61M	831.96M	918.59M
Invested Capital (Quarter)								452.60M	414.12M	368.20M	336.46M	287.06M	249.74M	252.36M	241.94M	206.88M	152.04M	91.29M	478.06M	775.19M	705.54M	629.84M	668.97M	670.26M	790.93M	1,121.05M	1,015.05M
Leverage & Solvency
Interest Coverage Ratio (Quarter)																								-0.00M	-39.22
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)								0.97	0.89	0.86	0.87	0.84	0.83	0.82	0.84	0.82	0.74	0.55	0.92	0.94	0.92	0.91	0.93	0.78	0.80	0.82	0.80
Times Interest Earned (Quarter)																								-0.00M	-39.22
Valuation
Enterprise Value (Quarter)								-435.59M	-407.52M	-376.57M	-323.15M	-291.84M	-248.14M	-256.01M	-238.21M	-207.73M	-157.82M	-123.10M	-453.55M	-778.84M	-723.67M	-642.27M	-677.49M	-597.03M	-791.89M	-1110.56M	-972.16M
Return Ratios
Return on Capital Employed (Quarter)									-28.55%	-35.93%	-41.90%	-54.18%	-61.64%	-62.19%	-65.47%	-77.91%	-108.04%	-180.63%	-82.74%	-42.07%	-41.69%	-49.99%	-59.06%	-64.49%	-60.85%	-47.95%	-43.53%
Return on Assets (Quarter)								0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%
Return on Equity (Quarter)								0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%